TB-500 (Research Grade)
TB-500 is a synthetic peptide generally described as a version or fragment associated with thymosin beta-4 (Tβ4), a naturally occurring peptide that has been studied in preclinical research for its role in cell migration, tissue repair, angiogenesis, and wound-healing related pathways. Published research around thymosin beta-4 has focused mainly on animal models and experimental systems rather than established clinical use for consumers.
Research context:
Interest in TB-500 is largely tied to the broader thymosin beta-4 literature, where researchers have explored possible effects in areas such as dermal healing, inflammation, and recovery-related biology. That said, current public discussion around TB-500 often outpaces the human evidence base, and recent medical commentary has noted that human clinical evidence for injury-recovery uses is essentially absent.
Important notice:
For laboratory research use only. Not for human consumption, injection, therapeutic, diagnostic, or veterinary use. TB-500 is not an approved medicine for general consumer use, and any references to biological activity are provided for scientific context only, not as claims of safety, effectiveness, or medical benefit. Regulatory scrutiny around peptides has increased, and the FDA has recently listed TB-500 among substances scheduled for advisory review in a compounding context.
Reviews
There are no reviews yet.